$VALN News

Valneva (VALN) Q2 2026 Earnings Call Transcript

Valneva: The Lyme Royalty Transition Changes The Earnings Model

Why Did VALN Stock Surge 24% Today?

Valneva SE (INRLF) (H1 2026) Earnings Call Highlights: Strategic Pivot and Lyme Vaccine ...

Valneva SE (VALN) Q2 2026 Earnings Call Transcript

Conference Call: Valneva Affirms FY2026 Sales Guidance of $169.795M-$187.360M vs $171.630M Est

Valneva Reports H1 2026 Product Sales Of €64.0M Down From €91.0M YoY, Net Loss Widens To €63.3M From €20.8M YoY

Declaration of shares and voting rights - Status as of July 31, 2026

Valneva to Report First Half 2026 Consolidated Financial Results on August 13, 2026

Declaration voting rights - June 30,2026

Valneva Announces Successful Outcome of its Annual General Meeting

Valneva SE (VALN) Shareholder/Analyst Call Prepared Remarks Transcript

Valneva Announces Availability of Documentation for its Annual General Meeting

VALNEVA:Declaration of shares and voting rights - Status as of May 31, 2026

Valneva SE (INRLF) Q1 2026 Earnings Call Highlights: Promising Vaccine Developments Amid ...

Valneva SE (VALN) Q1 2026 Earnings Call Transcript

Transcript: Valneva Q1 2026 Earnings Conference Call

Valneva Lowers FY2026 Sales Guidance from $180.443M-$197.906M to $169.795M-$187.360M vs $192.800M Est

Valneva Q1 EPS $(0.42) Misses $(0.21) Estimate, Sales $36.189M Miss $46.270M Estimate

Valneva to Report First Quarter 2026 Consolidated Financial Results on May 13, 2026